MediPort’s collaborative approach with key strategic partners provides the foundation of innovation and expertise on MediPorts IVD products. This allows us to meet the needs of innovating our testing products based on the varying dynamics of COVID-19.
Affinity BioMarker Labs at Imperial College London assist and advise us on existing and new IVD product development and research opportunities in the UK.
Sutton House Group offers a strategic consultative approach to product development, emerging technology insights and protocol testing development.
Medical Device Consultancy provide us the key insights into specialist medical device business development, regulatory affairs and quality management systems.
Abingdon Health are a leading technology-enabled lateral flow diagnostics company providing leading-edge rapid testing solutions. They provides us the ability for lateral flow assay development and manufacturing.
Bond Healthcare is one of key technology partners assisting us with developing and improving the diagnosing and tracking Covid-19 for both the Public and Private sectors with Our IVD connect digital platform.